These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14743469)

  • 1. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.
    Lapidus RG; Dang W; Rosen DM; Gady AM; Zabelinka Y; O'Meally R; DeWeese TL; Denmeade SR
    Prostate; 2004 Feb; 58(3):291-8. PubMed ID: 14743469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
    Harper E; Dang W; Lapidus RG; Garver RI
    Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel.
    Jackson JK; Gleave ME; Yago V; Beraldi E; Hunter WL; Burt HM
    Cancer Res; 2000 Aug; 60(15):4146-51. PubMed ID: 10945622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Armstrong DK; Fleming GF; Markman M; Bailey HH
    Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase.
    El Hilali N; Rubio N; Blanco J
    Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
    Li KW; Dang W; Tyler BM; Troiano G; Tihan T; Brem H; Walter KA
    Clin Cancer Res; 2003 Aug; 9(9):3441-7. PubMed ID: 12960135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
    Kumar Naraharisetti P; Yung Sheng Ong B; Wei Xie J; Kam Yiu Lee T; Wang CH; Sahinidis NV
    Biomaterials; 2007 Feb; 28(5):886-94. PubMed ID: 17067667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts.
    Xie M; Zhou L; Hu T; Yao M
    Anticancer Drugs; 2007 Apr; 18(4):459-66. PubMed ID: 17351398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model.
    Guinan P; Shaw M; Mirochnik Y; Slobodskoy L; Ray V; Rubenstein M
    Methods Find Exp Clin Pharmacol; 1998 Nov; 20(9):739-42. PubMed ID: 10022026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.
    Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME
    Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation sensitizing effect of estramustine is not dependent on apoptosis.
    Ståhlberg K; Kairemo K; Erkkilä K; Pentikäinen V; Sorvari P; Taari K; Dunkel L; Rannikko S
    Anticancer Res; 2005; 25(4):2873-8. PubMed ID: 16080540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.
    Shikanov A; Shikanov S; Vaisman B; Golenser J; Domb AJ
    Int J Pharm; 2008 Jun; 358(1-2):114-20. PubMed ID: 18406086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
    Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
    Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models.
    Xie X; Eberding A; Madera C; Fazli L; Jia W; Goldenberg L; Gleave M; Guns ES
    J Urol; 2006 May; 175(5):1926-31. PubMed ID: 16600800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres.
    Tzafriri AR; Lerner EI; Flashner-Barak M; Hinchcliffe M; Ratner E; Parnas H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):826-34. PubMed ID: 15701873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
    Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
    Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.